← Leaderboards
Gennadi Victor Glinsky
Metastat, Inc.
$2,357,411
Attributed
$2,357,411
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,357,411 · 2
By mechanism
R01$2,313,581 · 1
R43$43,830 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Neoplasm /Cancer Chemotherapy”
- Charles A Coltman · Southwest Oncology Group$171,655,324
- Norman Wolmark · Nsabp Foundation, Inc.$63,095,441
- Philip J Disaia · University Of California Irvine$41,530,194
- Walter J Curran · Thomas Jefferson University$37,520,030
- Samuel A Wells · Duke University$32,148,803
- Gregory H Reaman · National Childhood Cancer Foundation$19,436,422
Research focus
Neoplasm /Cancer ChemotherapyGene Induction /RepressionNeoplasm /Cancer GeneticsAthymic MouseWestern BlottingsAntineoplasticsClinical ResearchComplementary DnaHuman SubjectImmunofluorescence TechniqueLaboratory RabbitMessenger RnaMetastasisMicroarray TechnologyOncoproteinsPolymerase Chain ReactionProstate NeoplasmsAminesDna Directed Rna PolymeraseEnzyme ComplexEnzyme Linked Immunosorbent AssayEscherichia ColiBinding SitesGenetic Mapping
Grant awards (6)
TRANSCRIPTOME OF METASTATIC PROSTATE CANCER$368,313
R01 · FY2005 · CA
TRANSCRIPTOME OF METASTATIC PROSTATE CANCER$550,200
R01 · FY2004 · CA
TRANSCRIPTOME OF METASTATIC PROSTATE CANCER$571,708
R01 · FY2003 · CA
TRANSCRIPTOME OF METASTATIC PROSTATE CANCER$411,680
R01 · FY2002 · CA
TRANSCRIPTOME OF METASTATIC PROSTATE CANCER$411,680
R01 · FY2001 · CA
SYNTHETIC ANTIBACTERIAL PEPTIDES$43,830
R43 · FY2000 · GM